Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity
Open accessThe DOI matches its Crossref record; 57 of the 58 references it cites were found in a registry or an index.
Abstract
Elucidating the signalling mechanisms by which obesity leads to impaired insulin action is critical in the development of therapeutic strategies for the treatment of diabetes. Recently, mice deficient for S6 Kinase 1 (S6K1), an effector of the mammalian target of rapamycin (mTOR) that acts to integrate nutrient and insulin signals, were shown to be hypoinsulinaemic, glucose intolerant and have reduced beta-cell mass. However, S6K1-deficient mice maintain normal glucose levels during fasting, suggesting hypersensitivity to insulin, raising the question of their metabolic fate as a function of age and diet. Here, we report that S6K1-deficient mice are protected against obesity owing to enhanced beta-oxidation. However on a high fat diet, levels of glucose and free fatty acids still rise in S6K1-deficient mice, resulting in insulin receptor desensitization. Nevertheless, S6K1-deficient mice remain sensitive to insulin owing to the apparent loss of a negative feedback loop from S6K1 to insulin receptor substrate 1 (IRS1), which blunts S307 and S636/S639 phosphorylation; sites involved in insulin resistance. Moreover, wild-type mice on a high fat diet as well as K/K A(y) and ob/ob (also known as Lep/Lep) mice-two genetic models of obesity-have markedly elevated S6K1 activity and, unlike S6K1-deficient mice, increased phosphorylation of IRS1 S307 and S636/S639. Thus under conditions of nutrient satiation S6K1 negatively regulates insulin signalling.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“We discuss how pathways that “sense” nutrients within skeletal muscle are readily able to regulate insulin action.”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [37]
In the citing paper
“The mTOR/ p70S6 kinase pathway is a putative nutrient-sensing pathway, and overactivation of this pathway in cell-based systems, rodents, and humans is also associated with insulin resistance (37)(38)(39).”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [37]
In the citing paper
“Obese and type 2 diabetic rodents have increased mTOR/S6K signaling and this may contribute to insulin resistance [151-153].”
From AMPK and Exercise: Glucose Uptake and Insulin Sensitivity (2013) · cites this paper as [151]
Citations
Cites
Positional cloning of the mouse obese gene and its human homologue
Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., & Friedman, J. M. (1994) · Nature · doi:10.1038/372425a0 · Cited by 13,419 · cited 1×
“To test this further, two genetic models of obesity were examined: K/K A y and ob/ob mic”
MethodMootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Insulin signalling and the regulation of glucose and lipid metabolism
Saltiel, A. R., & Kahn, C. R. (2001) · Nature · doi:10.1038/414799a · Cited by 5,326 · cited 1×
“gif" NDATA ITEM> ]> Elucidating the signalling mechanisms by which obesity leads to impaired insulin action is critical in the development of therapeutic strategies for the treatment of diabete”
BackgroundA central role for JNK in obesity and insulin resistance
Hirosumi, J., Tuncman, G., Chang, L., Görgün, C. Z., Uysal, K. T., Maeda, K., Karin, M., & Hotamisligil, G. S. (2002) · Nature · doi:10.1038/nature01137 · Cited by 3,359 · cited 1×
“Protein extracts from tissue samples were analysed as describe”
MethodObesity and insulin resistance
Kahn, B. B., & Flier, J. S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10842 · Cited by 3,225
Patti, M. E., Butte, A. J., Crunkhorn, S., Cusi, K., Berria, R., Kashyap, S., Miyazaki, Y., Kohane, I., Costello, M., Saccone, R., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1032913100 · Cited by 1,952
The cytoplasmic body component TRIM5α restricts HIV-1 infection in Old World monkeys
Stremlau, M., Owens, C. M., Perron, M. J., Kiessling, M., Autissier, P., & Sodroski, J. (2004) · Nature · doi:10.1038/nature02343 · Cited by 1,816
Role of Fatty Acids in the Pathogenesis of Insulin Resistance and NIDDM
Boden, G. (1997) · Diabetes · doi:10.2337/diab.46.1.3 · Cited by 1,728 · cited 1×
“As increased circulating FFAs are implicated in insulin resistanc”
BackgroundHara, K., Yonezawa, K., Weng, Q.-P., Kozlowski, M. T., Belham, C., & Avruch, J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.23.14484 · Cited by 1,367
Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E
Fingar, D. C., Salama, S., Tsou, C., Harlow, E., & Blenis, J. (2002) · Genes & Development · doi:10.1101/gad.995802 · Cited by 1,093 · cited 4×
“a, S6K1 Thr 389 and S6 Ser 240/244 phosphorylation in fat of wild-type mice maintained on a NCD (2) or HFD (þ) for 4 months.”
BackgroundMethodInfluential
Cited by
Items 801–900 of 1,004
Alshehade, S. A., Alshawsh, M. A., Murugaiyah, V., Asif, M., Alshehade, O., Almoustafa, H. A., & Zarzour, R. H. A. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120732 · Cited by 44
Dietary methionine restriction improves glucose metabolism in the skeletal muscle of obese mice
Luo, T., Yang, Y., Xu, Y., Gao, Q., Wu, G., Jiang, Y., Sun, J., Shi, Y., & Le, G. (2019) · Food & Function · doi:10.1039/c8fo02571a · Cited by 44
Hindlet, P., Bado, A., Farinotti, R., & Buyse, M. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.125799 · Cited by 42
“However, this does not exclude the possibility that desensitization of insulin receptors could explain the lack of insulin action on PepT1 in this model (Um et al., 2004).”
BackgroundWang, A., Yang, F., Tian, Y., Su, J.-H., Gu, Q., Chen, W., Gong, S.-X., Ma, X., Qin, X.-P., & Jiang, Z. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.656139 · Cited by 49
“Ribosomal protein S6 kinase 1 (S6K1) is an important effector protein downstream of mTOR, which has Ser/Thr kinase activity and mediates protein synthesis, mRNA processing, cell growth, and survival (Um et al., 2004; Yuan et al., 2013).”
BackgroundThe serine phosphorylations in the IRS-1 PIR domain abrogate IRS-1 and IR interaction
Woo, J. R., Bae, S.-H., Wales, T. E., Engen, J. R., Lee, J., Jang, H., & Park, S. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2401716121 · Cited by 46
“Also, phosphorylations of IRS - 1 Ser302 and Ser307 are significantly increased in the hepatocytes of both HFD - induced and Ob/Ob mice (26), and the yeast trihybrid (Y3H) studies show that JNK1 directly phosphorylates Ser302 or Ser307 to result in the blocking of IRS - 1 and IR interaction (27).”
BackgroundWijngaarden, M. A., Bakker, L. E. H., van der Zon, G. C., Hoen, P. A. C. ’., van Dijk, K. W., Jazet, I. M., Pijl, H., & Guigas, B. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00215.2014 · Cited by 45
Ghrelin contributes to derangements of glucose metabolism induced by rapamycin in mice
Xu, G., Wang, Z., Li, Y., Li, Z., Tang, H. W., Zhao, J., Xiang, X., Ding, L., Ma, L., Yuan, F., et al. (2012) · Diabetologia · doi:10.1007/s00125-012-2509-1 · Cited by 42
Elumalai, A., & Anuradha, C. V. (2012) · Nutrition Research · doi:10.1016/j.nutres.2012.06.002 · Cited by 42
Koschei the immortal and anti-aging drugs
Blagosklonny, M. V. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.520 · Cited by 42
Copps, K. D., Hançer, N. J., Qiu, W., & White, M. F. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.714915 · Cited by 41
“Phosphorylation of this site is also diminished in S6k1 knock-out mice (24).”
BackgroundER Stress Activates the TOR Pathway through Atf6
Allen, D., & Seo, J. H. (2018) · Journal of Molecular Signaling · doi:10.5334/1750-2187-13-1 · Cited by 42
“Further, S6K null mice are insulinsensitive and resist diet-induced obesity [29].”
BackgroundMicroRNAs link chronic inflammation in childhood to growth impairment and insulin-resistance
Cirillo, F., Lazzeroni, P., Catellani, C., Sartori, C., Amarri, S., & Street, M. E. (2018) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2017.12.004 · Cited by 43
Huang, H., Chen, P., Liang, X., Wu, X., Wang, C., Gu, X., & Xue, M. (2019) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2019.04.294 · Cited by 41
The contribution of the gut-liver axis to the immune signaling pathway of NAFLD
Liu, J., Wu, A., Cai, J., She, Z., & Li, H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.968799 · Cited by 47
“The continuous activation of mTORC1 leads to serine phosphorylation of IRS1 and IRS2, interferes with signal transduction, and targets IRS1 for protein decomposition through the proteasome pathway (61, 62).”
BackgroundAlterations to mTORC1 signaling in the skeletal muscle differentially affect whole-body metabolism
Guridi, M., Kupr, B., Romanino, K., Lin, S., Falcetta, D., Tintignac, L. A. J., & Rüegg, M. A. (2016) · Skeletal Muscle · doi:10.1186/s13395-016-0084-8 · Cited by 51
“mTORC1 is also highly active in the liver and skeletal muscle of obese and high-fat-fed rodents [17, 42].”
BackgroundIntestinal mTOR regulates GLP-1 production in mouse L cells
Xu, G., Li, Z., Ding, L., Tang, H. W., Guo, S., Liang, H., Wang, H., & Zhang, W. (2015) · Diabetologia · doi:10.1007/s00125-015-3632-6 · Cited by 41
Denhez, B., Rousseau, M., Spino, C., Dancosst, D.-A., Dumas, M.-È., Guay, A., Lizotte, F., & Geraldes, P. (2020) · Scientific Reports · doi:10.1038/s41598-020-78376-1 · Cited by 212
Fritsche, L., Neukamm, S. S., Lehmann, R., Kremmer, E., Hennige, A. M., Hunder-Gugel, A., Schenk, M., Häring, H., Schleicher, E. D., & Weigert, C. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00409.2010 · Cited by 49
Shin, N. R., Bose, S., Wang, J., Ansari, A., Lim, S.-K., Chin, Y., Choi, H., & Kim, H. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.02271 · Cited by 42
“Activation of AMPK suppresses the gene and protein expression of SREBP1c (Zhou et al., 2001; Um et al., 2004; You et al., 2004), the key transcription factor regulating fatty acid synthesis.”
BackgroundMethodLoss of Tbk1 kinase activity protects mice from diet-induced metabolic dysfunction
Cruz, V. H., Arner, E. N., Wynne, K. W., Scherer, P. E., & Brekken, R. A. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.06.007 · Cited by 41
“Accordingly, S6K1-deficient mice demonstrate a comparable phenotype to Tbk1D/D mice on HFD with lower body weights and insulin hypersensitivity [39,40].”
Wipperman, M. F., Montrose, D. C., Gotto, A. M., & Hajjar, D. P. (2019) · American Journal Of Pathology · doi:10.1016/j.ajpath.2018.11.013 · Cited by 42
Kido, K., Sase, K., Yokokawa, T., & Fujita, S. (2020) · Scientific Reports · doi:10.1038/s41598-020-65397-z · Cited by 43
NQO1 protects obese mice through improvements in glucose and lipid metabolism
Francesco, A. D., Choi, Y., Bernier, M., Zhang, Y., Díaz‐Ruiz, A., Aon, M. A., Kalafut, K. C., Ehrlich, M. R., Murt, K. N., Ali, A., et al. (2020) · npj Aging and Mechanisms of Disease · doi:10.1038/s41514-020-00051-6 · Cited by 45
Drissi, F. D., LAHFA, F. B., Gonzalez, T., Peiretti, F., Tanti, J., Haddad, M., Fabre, N., & Govers, R. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.113772 · Cited by 43
Lim, M. J., Choi, K. J., Ding, Y., Kim, J. H., Kim, B. S., Kim, Y. H., Lee, J., Choe, W., Kang, I., Ha, J., et al. (2007) · Molecular Endocrinology · doi:10.1210/me.2007-0114 · Cited by 45
“IRS-1 contains greater than 100 potential serine phosphorylation sites (49) that are recognized by many kinases, including JNK (50), mTOR (18), PKCs (51), p70 (52), and ROK (34–36).”
BackgroundGe, Y., Yoon, M., & Chen, J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.262881 · Cited by 45
Immunomodulation at epithelial sites by obesity and metabolic disease
Cheung, K. P., Taylor, K. R., & Jameson, J. (2011) · Immunologic Research · doi:10.1007/s12026-011-8261-7 · Cited by 42
Inhibition of the PI3K Pathway: Hope We Can Believe in?
van der Heijden, M. S., & Bernards, R. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-3004 · Cited by 47
The role of PAS kinase in regulating energy metabolism
Hao, H.-X., & Rutter, J. P. (2008) · IUBMB Life · doi:10.1002/iub.32 · Cited by 46
Computational modelling of the regulation of Insulin signalling by oxidative stress
Smith, G. R., & Shanley, D. P. (2013) · BMC Systems Biology · doi:10.1186/1752-0509-7-41 · Cited by 44
“The Serine phosphorylation by PKC is a simple representation in the model of the negative feedback loop that stabilizes the basal response of insulin signalling [69].”
Licorice flavonoid oil enhances muscle mass in KK-A mice
Yoshioka, Y., Yamashita, Y., Kishida, H., Nakagawa, K., & Ashida, H. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.05.024 · Cited by 39
mTORC1 in energy expenditure: consequences for obesity
Allard, C., Miralpeix, C., López-Gambero, A. J., & Cota, D. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-023-00934-0 · Cited by 40
“To prevent mTORC1 overstimulation, the mTORC1 substrate ribosomal protein S6 kinase 1 (S6K1) and growth factor receptor binding protein 10 (GRB10) act as negative feedback on PI3K–AKT signalling 22–24 .”
mTOR function in skeletal muscle: a focal point for overnutrition and exercise
Rivas, D. A., Lessard, S. J., & Coffey, V. G. (2009) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h09-073 · Cited by 40
“2A) (Crozier et al. 2003; Mordier and Iynedjian 2007; Tremblay et al. 2007; Um et al. 2004; Khamzina et al. 2005; Korsheninnikova et al. 2006).”
BackgroundFierz, Y., Novosyadlyy, R., Vijayakumar, A., Yakar, S., & LeRoith, D. (2010) · Endocrine Related Cancer · doi:10.1677/erc-10-0091 · Cited by 39
“Moreover, S6 kinase-deficient mice display reduced body adiposity (Um et al. 2004).”
BackgroundMetformin: An Inhibitor of mTORC1 Signaling
Melnik, B. C., & Schmitz, G. (2014) · Cited by 45
Srinivas, K. P., Remadevi, V., Dan, V. M., Sajitha, I. S., Prakash, R., Rahul, P. V., Santhoshkumar, T. R., Lakshmi, S., & Pillai, M. R. (2016) · Oncotarget · doi:10.18632/oncotarget.8131 · Cited by 41
“Feedback inhibition of AKT signaling was known to limit the growth of tumors, hinting at the proper balancing of PI3K-AKT by S6K in cells under normal physiology, which when disturbed has serious implications in metabolic diseases and tumorigenesis [4, 52-54].”
BackgroundmTOR signaling in Brown and Beige adipocytes: implications for thermogenesis and obesity
Ye, Y., Liu, H., Zhang, F., & Hu, F. (2019) · Nutrition & Metabolism · doi:10.1186/s12986-019-0404-1 · Cited by 42
“Magnuson B, Ekim B, Fingar DC. Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks.”
BackgroundInfluentialGao, Y., & Tian, T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411811 · Cited by 43
PRAS40: Target or modulator of mTORC1 signalling and insulin action?
Nascimento, E. B. M., & Ouwens, D. M. (2009) · Archives of Physiology and Biochemistry · doi:10.1080/13813450902988580 · Cited by 42
“Accordingly, genetic ablation of S6K1 (Um et al., 2004), or lowering mTORC1 activity with rapamycin (Tremblay et al., 2005) or chronic exercise (Glynn et al., 2008) reduces IRS1 serine phosphorylation and reverses the inhibition of the PI3K-PKB/Akt pathway in the liver, skeletal muscle, and adipose tissue.”
BackgroundInfluentialA Dynamic Analysis of IRS-PKR Signaling in Liver Cells: A Discrete Modeling Approach
Wu, M., Yang, X., & Chan, C. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008040 · Cited by 44
“A number of signaling molecules, such as IkB kinase (IKK) [31], mammalian target of rapamycin (mTOR) [32], PKCf [33], S6 Kinase 1 (S6K1) [34], ERK [35] and JNK [36,37] have been shown to function as IRS serine kinases that induce insulin resistance by promoting the inhibitory phosphorylation of IRS (reviewed in [26,38…”
Backgroundm TORC 1 and m TORC 2 have largely distinct functions in Purkinje cells
Angliker, N., Burri, M., Zaichuk, M., Fritschy, J., & Rüegg, M. A. (2015) · European Journal of Neuroscience · doi:10.1111/ejn.13051 · Cited by 41
“Inactivation of mTORC1 by raptor depletion increases Akt signalling (Cloetta et al., 2013) because the inhibitory feedback loop via S6K is damped (Um et al., 2004).”
BackgroundChung, H. S., Hwang, H., Hwang, S. Y., Kim, N. H., Seo, J. A., Kim, S. G., Kim, N. H., Baik, S. H., Choi, K. M., & Yoo, H. J. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.07.024 · Cited by 42
Okamoto, Y., Higashiyama, H., Rong, J. X., McVey, M. J., Kinoshita, M., Asano, S., & Hansen, M. K. (2007) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2007.02.007 · Cited by 38
Zhu, R., Dann, E., Yan, J., Retana, J. R., Goto, R., Guitche, R. C., Brixi, L., Ota, M., Hartman, A., Roth, T. L., et al. (2026) · Cell · doi:10.1016/j.cell.2026.08.002 · Cited by 57
Genetics and Pharmacology of Longevity
Castillo-Quan, J. I., Kinghorn, K. J., & Bjedov, I. (2015) · Advances in genetics · doi:10.1016/bs.adgen.2015.06.002 · Cited by 38
Ahn, J., & Lee, M. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.06.034 · Cited by 38
“The data from several laboratories strongly support a role for p70S6K in the promotion of autophagy [36,37].”
BackgroundS6K1 determines the metabolic requirements for BCR-ABL survival
Barger, J. F., Gallo, C. A., Tandon, P., Liu, H., Sullivan, A., Grimes, H. L., & Plas, D. R. (2013) · Oncogene · doi:10.1038/onc.2012.70 · Cited by 37
“Conversely, inactivation of S6K1 in muscle triggers increased expression of CPT1 mRNA (47).”
Lightell, D., Moss, S. C., & Woods, T. C. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.12.016 · Cited by 38
Caloric restriction maintains stem cells through niche and regulates stem cell aging
Maharajan, N., Vijayakumar, K. A., Jang, C. H., & Cho, G. (2019) · Journal of Molecular Medicine · doi:10.1007/s00109-019-01846-1 · Cited by 39
Diet-induced dyslipidemia induces metabolic and migratory adaptations in regulatory T cells
Amersfoort, J., Schaftenaar, F. H., Douna, H., van Santbrink, P. J., van Puijvelde, G. H. M., Slütter, B., Foks, A. C., Harms, A. C., Moreno-Gordaliza, E., Wang, Y., et al. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa208 · Cited by 43
Phosphorylation of ribosomal protein S6 mediates compensatory renal hypertrophy
Xu, J., Chen, J., Dong, Z., Meyuhas, O., & Chen, J. (2014) · Kidney International · doi:10.1038/ki.2014.302 · Cited by 40
Milo, M., Cacciabue-Rivolta, D. I., Kneebone, A., van Doorninck, H., Johnson, C. M., Lawoko‐Kerali, G., Niranjan, M., Rivolta, M. N., & Holley, M. C. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007144 · Cited by 40
“In Drosophila, MAP4K3 is required for maximal activation of S6 kinase [80], which is part of a negative feedback to insulin/IGF receptor signalling [81,82].”
BackgroundPhosphorylation of Irs1 at SER-522 Inhibits Insulin Signaling
Giraud, J., Haas, M., Feener, E. P., Copps, K. D., Dong, X., Dunn, S. L., & White, M. F. (2007) · Molecular Endocrinology · doi:10.1210/me.2007-0159 · Cited by 38
Minami, K., Tambe, Y., Watanabe, R., Isono, T., Haneda, M., Isobe, K., Kobayashi, T., Hino, O., Okabe, H., Chano, T., et al. (2007) · Journal of Virology · doi:10.1128/jvi.01063-07 · Cited by 38
“Altered signaling by mTOR has been shown to be linked to several diseases, including cancer, diabetes, neurodegenerative disorders, and obesity (9, 20, 23, 25, 40).”
BackgroundRanade, S. D., Alegaon, S. G., Khatib, N. A., Gharge, S., Kavalapure, R. S., & Kumar, B. R. P. (2024) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2024.138359 · Cited by 37
Regulating Energy Balance: The Substrate Strikes Back
Flier, J. S. (2006) · Science · doi:10.1126/science.1127971 · Cited by 38
Nakamura, M., Tsukada, H., Seki, G., Satoh, N., Mizuno, T., Fujii, W., Horita, S., Moriya, K., Sato, Y., Kume, H., et al. (2019) · Kidney International · doi:10.1016/j.kint.2019.08.021 · Cited by 38
Type 2 diabetes – unmet need, unresolved pathogenesis, mTORC1-centric paradigm
Bar‐Tana, J. (2020) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-020-09545-w · Cited by 44
Phosphorylation and degradation of S6K1 (p70S6K1) in response to persistent JNK1 Activation
Zhang, J., Gao, Z., & Ye, J. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.06.013 · Cited by 40
“In vivo, S6K knockout protects mice from obesity-induced insulin resistance [8].”
BackgroundAmino acid‐dependent modulation of glucose metabolism in humans
Krebs, M. (2005) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2005.01506.x · Cited by 37
Huang, S.-J., Yang, W., Lin, Y., Wang, H.-C., & Chen, C. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.04.147 · Cited by 39
Perspectives of Targeting mTORC1–S6K1 in Cardiovascular Aging
Ming, X., Montani, J., & Yang, Z. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00005 · Cited by 38
“In addition, drugs more specifically inhibiting S6K1 rather than mTORC1 should be developed and the effects of targeting mTORC1 or S6K1 on aging-related cardiovascular diseases and cardiovascular aging and beyond should be investigated.”
BackgroundZhao, X., Lu, S., Nie, J., Hu, X., Luo, W., Wu, X., Liu, H., Feng, Q., Chang, Z., Liu, Y., et al. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.00144-14 · Cited by 36
The Tellurium compound, AS101, increases SIRT1 level and activity and prevents type 2 diabetes
Halperin-Sheinfeld, M., Gertler, A. A., Okun, E., Sredni, B., & Cohen, H. Y. (2012) · Aging · doi:10.18632/aging.100468 · Cited by 36
“The insulin signal cascades, which include PKB/Akt through PI3K and mTOR, stimulate S6K1, resulting in a negative feedback, which may cause insulin resistance [55, 56].”
BackgroundLiu, H., Wei, C., Chen, Y., Chen, Y., & Chang, S. (2016) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201501064 · Cited by 37
“In animal models of obesity, S6k1 induced serine phosphorylation of IRS1, thereby suppressing insulin signaling pathway [26].”
BackgroundCornier, M.-A., Bessesen, D. H., Gurevich, I., Leitner, J. W., & Draznin, B. (2006) · Diabetologia · doi:10.1007/s00125-006-0148-0 · Cited by 35
“First, it became apparent that serine phosphorylation of IRS proteins either by PI 3-kinase itself, or by protein kinase C, by a mechanism dependent on molecular target of rapamycin (mTOR), or by other kinases, can reduce the ability of IRS proteins to attract PI 3-kinase, thus minimising its activation [4–8].”
BackgroundCentral Leucine Sensing in the Control of Energy Homeostasis
Schwartz, G. J. (2012) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2012.12.001 · Cited by 37
“In mice, constitutive, systemic deletion of S6K1 protects against diet-induced obesity and enhances insulin sensitivity, yet promotes glucose intolerance.(4) In rats, BCAAsupplementation of a high-fat diet (HFD) reducesweight gainwhile increasing insulin resistance, suggesting that, in the context of HFD, dietary BCAA”
FoxO1 at the nexus between fat catabolism and longevity pathways
Lettieri‐Barbato, D., Aquilano, K., & Ciriolo, M. R. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.08.004 · Cited by 37
Geuna, E., Roda, D., Rafii, S., Jiménez, B., Capelán, M., Rihawi, K., Montemurro, F., Yap, T. A., Kaye, S. B., Bono, J. S. D., et al. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.373 · Cited by 39
“In particular, mTORC1 has a crucial role in end organ insulin uptake and its chronic activation, as shown in preclinical models, is associated with insulin resistance through ribosomal protein S6 kinase beta-1 (S6K1; Um et al, 2004; Khamzina et al, 2005; Laplante and Sabatini, 2012).”
BackgroundFeast and famine: Adipose tissue adaptations for healthy aging
Lettieri‐Barbato, D., & Aquilano, K. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.05.007 · Cited by 36
“It has been observed that mice lacking the downstream target of mTOR, S6 protein kinase 1 KO (S6K1) have reduced adiposity, show enhanced mitochondrial oxidative metabolism in adipose tissue and insulin sensitivity, and are resistant to diet- and aging-induced obesity (Um et al., 2004).”
BackgroundEl‐Kadi, S. W., Boutry, C., Suryawan, A., Gazzaneo, M. C., Orellana, R. A., Srivastava, N., Nguyen, H. V., Kimball, S. R., Fiorotto, M. L., & Davis, T. A. (2018) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqy133 · Cited by 37
“Prolonged hyperphosphorylation of S6K1 (35) serves as a negative feedback process controlling IRS-1 activity (36) through serine/threonine phosphorylation (37), which leads to its degradation (38, 39).”
BackgroundKorat, A. V. A., Malik, V., Furtado, J. D., Sacks, F. M., ROSNER, B. A., Rexrode, K. M., Willett, W. C., Mozaffarian, D., Hu, F. B., & Sun, Q. (2019) · Journal of Nutrition · doi:10.1093/jn/nxz240 · Cited by 42
Regulation of Adipocyte and Macrophage Functions by mTORC1 and 2 in Metabolic Diseases
Festuccia, W. T. (2020) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201900768 · Cited by 37
Molecular Insulin Actions Are Sexually Dimorphic in Lipid Metabolism
Ortiz-Huidobro, R. I., Velasco, M., Larqué, C., Escalona, R., & Hiriart, M. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.690484 · Cited by 36
“Moreover, there is an increase of S6K1 signaling in tissues from diabetic individuals, and there is evidence that S6K1 removal in mice protects them from diet-induced obesity and insulin resistance (106).”
BackgroundZhang, W., Zhang, C., Fritze, D. M., Chai, B., Li, J., & Mulholland, M. W. (2013) · Experimental Physiology · doi:10.1113/expphysiol.2013.074930 · Cited by 39
“In contrast, absence of the mTOR downstream target, S6 kinase 1, protects against diet-induced obesity and improves insulin sensitivity in mice (Um et al. 2004).”
BackgroundMethods for Studying Signal‐Dependent Regulation of Translation Factor Activity
Wang, X., & Proud, C. G. (2007) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(07)31007-0 · Cited by 37
Evidence for a regulatory role of Cullin-RING E3 ubiquitin ligase 7 in insulin signaling
Scheufele, F., Wolf, B., Kruse, M., Hartmann, T., Lempart, J., Muehlich, S., Pfeiffer, A. F. H., Field, L. J., Charron, M. J., Pan, Z., et al. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.11.005 · Cited by 42
“In further support of the role of the mTORC1/S6K1–IRS1 feedback loop in the pathogenesis of type 2 diabetes, S6K1-deficient mice displayed enhanced insulin sensitivity when chronically maintained on a high fat diet (35).”
BackgroundDungan, C. M., Wright, D. C., & Williamson, D. L. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.10.032 · Cited by 36
“Hyperactive mTORC1 negatively feeds back to inhibit the insulin receptor substrate-1 (IRS-1) by reducing tyrosine phosphorylation and promoting serine phosphorylation [9,12], downregulating insulin signaling.”
BackgroundMiller, A. M., Brestoff, J. R., Phelps, C. B., Berk, E. Z., & Reynolds, T. H. (2008) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.90428.2008 · Cited by 36
Stanimirović, J., Obradovic, M. M., Jovanović, A., Sudar-Milovanovic, E. M., Zafirovic, S. S., Pitt, S. J., Stewart, A. J., & Isenović, E. R. (2016) · Nitric Oxide · doi:10.1016/j.niox.2016.02.007 · Cited by 38
Loss of PTEN selectively desensitizes upstream IGF1 and insulin signaling
Lackey, J., Barnett, J., Davidson, L., Batty, I. H., Leslie, N. R., & Downes, C. P. (2007) · Oncogene · doi:10.1038/sj.onc.1210520 · Cited by 38
“…to our work, with particular attention focusing on the mTOR/S6K-mediated inhibitory phosphorylation and degradation of IRS1 (Harrington et al., 2004; Um et al., 2004) and additional pathways downstream of mTOR (Fisher and White, 2004; Pirola et al., 2004; Harrington et al., 2005; Um et al., 2006).”
Mechanisms of insulin secretion in malnutrition: modulation by amino acids in rodent models
de Oliveira, C. A. M., Latorraca, M. Q., de Mello, M. A. R., & Carneiro, E. M. (2010) · Amino Acids · doi:10.1007/s00726-010-0716-y · Cited by 34
“123 2003; Li et al. 2004; Um et al. 2004 ). The mechanisms by which amino acids enhance insulin secretion are varied.”
BackgroundHebbar, P., Nizam, R., Melhem, M., Alkayal, F., Elkum, N. B., John, S. E., Tuomilehto, J., Alsmadi, O. A., & Thanaraj, T. A. (2018) · Journal of Lipid Research · doi:10.1194/jlr.p080218 · Cited by 36
Rios-Fuller, T. J., Mahé, M., Walters, B., Abbadi, D., Pérez-Baos, S., Gadi, A., Andrews, J. J., Katsara, O., Vincent, C. T., & Schneider, R. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155301 · Cited by 43
“S6K1 inhibition has been suggested as a new therapeutic target to improve glucose disposal in obese patients, with one study demonstrating that S6K KO mice fed with a high-fat diet (HFD) were protected against diet-induced obesity, whereas S6K KO mice were still insulin sensitive [181].”
BackgroundREDD1 promotes obesity-induced metabolic dysfunction via atypical NF-κB activation
Lee, D., Kim, T., Byeon, J., Park, M., Kim, S., Kim, J., Choi, S., Lee, G., Park, C., Lee, K. W., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34110-1 · Cited by 36
Shi, F., & Collins, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411497 · Cited by 35
Varma, S., & Khandelwal, R. L. (2006) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2006.07.016 · Cited by 39
Yaspelkis, B. B., Lessard, S. J., Reeder, D. W., Limon, J. J., Saito, M., Rivas, D. A., Kvasha, I., & Hawley, J. A. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00230.2007 · Cited by 34
“It has been reported that increased IRS-1 serine phosphorylation prevents the insulin-signaling cascade from becoming fully activated (25, 35, 53, 60) and is related to increased diacylglycerol (DAG) accumulation in the skeletal muscle (35, 48).”
BackgroundMammalian target of the rapamycin pathway is involved in non-alcoholic fatty liver disease
Wang, X. (2010) · Molecular Medicine Reports · doi:10.3892/mmr.2010.365 · Cited by 42
Tzeng, T., Kong, L.-R., Chen, C., Shaw, C.-C., & Yang, C. (2009) · Plant and Cell Physiology · doi:10.1093/pcp/pcp114 · Cited by 34
“Interestingly, alteration of NAP expression in Arabidopsis ( Sablowski and Meyerowitz 1998 ), or ectopic expression of SUP in transgenic petunia, tobacco ( Kater et al. 2000 ) and Arabidopsis ( Yun et al. 2002 ), caused”
BackgroundSchloesser, A., Campbell, G. M., Glüer, C., Rimbach, G. H., & Huebbe, P. (2015) · Rejuvenation Research · doi:10.1089/rej.2014.1630 · Cited by 36
Tuberous Sclerosis and Insulin Resistance: Unlikely Bedfellows Reveal A TORrid Affair
Shah, O. J., & Hunter, T. R. (2004) · Cell Cycle · doi:10.4161/cc.4.1.1343 · Cited by 41
The Mammalian Target of Rapamycin Kinase and Tumor Growth Inhibition
Boulay, A., & Lane, H. A. (2007) · Springer eBooks · doi:10.1007/978-3-540-31209-3_7 · Cited by 35
The mTOR Pathway in the Control of Protein Synthesis
Steiner, J. L., Gordon, B. S., Lang, C. H., Shand, P. J., Napper, S., Dadgar, S., Arsenault, R. J., Trost, B., Scruten, E., KUSALIK, A. J., et al. (2015) · Cited by 33
Cannarella, R., Curto, R., Condorelli, R. A., Lundy, S. D., Vignera, S. L., & Calogero, A. E. (2024) · Nature Communications · doi:10.1038/s41467-024-49765-1 · Cited by 37
“Increased phosphorylation of IRS1 has also been reported in insulin-resistant rodents 71,72 .”
BackgroundWhey protein isolate protects against diet-induced obesity and fatty liver formation
Shi, J. P., Tauriainen, E., Martonen, E., Finckenberg, P., Ahlroos-Lehmus, A., Tuomainen, A. M., Pilvi, T. K., Korpela, R., & Mervaala, E. M. A. (2011) · International Dairy Journal · doi:10.1016/j.idairyj.2011.03.006 · Cited by 34
Nutrient withdrawal rescues growth factor-deprived cells from mTOR-dependent damage
Panieri, E., Toietta, G., Mele, M., Labate, V., Ranieri, S. C., Fusco, S., Tesori, V., Antonini, A., Maulucci, G., Spirito, M. D., et al. (2010) · Aging · doi:10.18632/aging.100183 · Cited by 38
“Hyperactivation of the mTOR/S6K axis has recently drawn significant attention as a key factor in the establishment of obesity and insulin resistance by nutrient overload [13].”
Varusai, T., & Nguyen, L. K. (2018) · Scientific Reports · doi:10.1038/s41598-017-18400-z · Cited by 37
Fatty acid oxidation is required for embryonic stem cell survival during metabolic stress
Yan, H., Malik, N., Kim, Y., He, Y., Li, M., Dubois, W., Liu, H., Peat, T. J., Nguyen, J. T., Tseng, Y., et al. (2021) · EMBO Reports · doi:10.15252/embr.202052122 · Cited by 37
“S6K1, a downstream target of mTOR, also regulates FAO (Um et al, 2004).”
Targeting colonic macrophages improves glycemic control in high-fat diet-induced obesity
Rohm, T. V., Keller, L., Bosch, A. J. T., AlAsfoor, S., Baumann, Z., Thomas, A., Wiedemann, S. J., Steiger, L., Dalmas, É., Wehner, J., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-03305-z · Cited by 34
“To block GLP-1 or parasympaticus action, 236 μg/kg exendin (9-39) (#H-8740, Bachem) or 5mg/kg atropine (#A0257-5G, Sigma), respectively, were i.”
Background
Metadata
- Authors
- Um, S. H., Frigerio, F., Watanabe, M., Picard, F., Joaquin, M., Sticker, M., Fumagalli, S., Allegrini, P. R., Kozma, S. C., Auwerx, J., & Thomas, G.
- Affiliations
- Friedrich Miescher Institute (CH)
- Centre National de la Recherche Scientifique (FR)
- Novartis (Switzerland) (CH)
- Corresponding author
- Thomas, George
- ORCID
- Venue
- Nature
- Published
- 2004-08-11
- Volume
- 431
- Issue
- 7005
- Pages
- 200-205
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2107674876
- Cited by
- 1,677
- References
- 58
- Citations by year
- 2026: 29 · 2025: 30 · 2024: 36 · 2023: 53 · 2022: 57 · 2021: 68 · 2020: 59 · 2019: 56 · 2018: 74 · 2017: 71 · 2016: 84 · 2015: 99 · 2014: 86 · 2013: 101 · 2012: 134
- FWCI
- 25.05
- Type
- journal article
- Language
- en
- Open access
- green
- infoscience.epfl.ch
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion, cc-by-nc-nd)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- S6K1, mTOR signaling, insulin sensitivity, insulin resistance, obesity, high-fat diet, fatty acid beta-oxidation, IRS-1 phosphorylation, beta-cell mass, impaired glucose tolerance, ob/ob mice, leptin deficiency
- MeSH terms
- Aging, Animals, Blood Glucose, Dietary Fats, Enzyme Activation, Fasting, Fatty Acids, Nonesterified, Insulin, Insulin Resistance, Lipolysis, Male, Mice, Inbred C57BL, Obesity, Oxidation-Reduction, Phosphoproteins, Phosphorylation, Receptor, Insulin, RNA, Messenger, Signal Transduction, Gene Deletion, Adipocytes, Mice, Knockout, Ribosomal Protein S6 Kinases, 70-kDa, Mice, Insulin Receptor Substrate Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.